|1.||Livant, D L: 1 article (01/2000)|
|2.||Upadhyaya, A: 1 article (01/2000)|
|3.||Brabec, R K: 1 article (01/2000)|
|4.||Markwart, S: 1 article (01/2000)|
|5.||Allen, D L: 1 article (01/2000)|
|6.||Pienta, K J: 1 article (01/2000)|
|7.||Kurachi, K: 1 article (01/2000)|
01/15/2000 - "Whether initiated after MLL cell injection or only after MLL tumor removal, Ac-PHSCN-NH2 treatment reduced the numbers of MLL lung colonies and micrometastases by 40- to >100-fold, whereas Ac-HSPNC-NH2 was inactive. "
01/15/2000 - "MLL tumor cryosections immunostained with anti-PECAM-1 showed that Ac-PHSCN-NH2 inhibited neovascularization by 12-fold during this time. "
01/15/2000 - "MLL tumor growth in rats treated with Ac-PHSCN-NH2 beginning 1 day after MLL cell injection was reduced by 99.9% during the first 16 days of treatment, although subsequent tumor growth occurred. "
01/15/2000 - "with 100,000 MLL cells were treated systemically by i.v. injection three times weekly with 1 mg of either Ac-PHSCN-NH2 or Ac-HSPNC-NH2 beginning 24 h later, three times weekly with 1 mg of Ac-PHSCN-NH2 beginning only after surgery to remove large (2 cm) MLL tumors, or were left untreated. "
|2.||Neoplasm Metastasis (Metastasis)